NewsRx

Search our medical news database

Affymetrix Inc.

Affymetrix Launches 3' IVT Express Kit for Faster, More Reliable Target Preparation

Published in Oncology Business Week, September 21st, 2008

Affymetrix Inc. (Nasdaq:AFFX) announced the launch of its 3' IVT Express Kit, a faster and more reliable option for manual target preparation on Affymetrix' industry-standard 3' IVT array cartridges. The kit offers new streamlined protocols and requires less starting sample material, enabling researchers to generate high-quality gene expression results faster than before.

Using less starting material is of benefit to cancer researchers because samples are precious. The 3' IVT Express Kit requires only 50 ng per sample, which is up to up to 20 times less than the previous One Cycle Kit. The other key benefit is that assays can be run in just one day with 500 ng of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook